Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 7
Submit an article Journal homepage
355
Views
9
CrossRef citations to date
0
Altmetric
Letters

Cladribine therapy in adults with advanced Langerhans cell histiocytosis

Marian SchiniDepartment of Pathophysiology, National University of Athens, GreeceCorrespondence[email protected]
,
Polyzois MakrasDepartment of Endocrinology and Diabetes, 251 Hellenic Air Force General Hospital, Athens, Greece
,
George KanakisDepartment of Pathophysiology, National University of Athens, Greece
,
Michael VoulgarelisDepartment of Pathophysiology, National University of Athens, Greece
&
Gregory KaltsasDepartment of Pathophysiology, National University of Athens, Greece
Pages 1541-1543 | Received 23 Aug 2012, Accepted 22 Oct 2012, Published online: 26 Nov 2012

References

  • Baumgartner I, Hochstetter A, Baumert B, et al. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol 1997;28:9–14.
  • Arico M, Girschikofsky M, Genereau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003;39:2341–2348.
  • Makras P, Piaditis G, Kaltsas G. Systemic and endocrine manifestations of Langerhans’ cell histiocytosis: current concepts in diagnosis and management. Expert Rev Endocrinol Metab 2007; 2:773–783.
  • Tatevossian R, Nanduri V, Salotti J, et al. Adults with LCH – orphans with an orphan disease. Clin Med 2006;6:404–408.
  • Nezelof C, Frileux-Herbet F, Cronier-Sachot J. Disseminated histiocytosis X. Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979;44:1824–1838.
  • Saven A, Burian C. Cladribine activity in adult Langerhans cell histiocytosis. Blood 1999;93:4125–4130.
  • Biswas G, Khadwal A, Arora B, et al. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience. Indian J Cancer 2007;44:137–141
  • Mottl H, Starý J, Chánová M, et al. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine. Leuk Lymphoma 2006;47:1881–1884.
  • Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:81–84.
  • Saven A, Rosenblatt JD. 2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med 1993;329:734–735.
  • Grau J, Ribera JM, Tormo M, et al. Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients. Med Clin (Barc) 2001;116:339–342.
  • Pardanani A, Phyliky RL, Li CY, et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003;78:301–306.
  • Nichols KE, Arceci RJ. BRAF, a piece of the LCH puzzle. Blood 2010;116:1825–1827.
  • Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010;116:1919–1923.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.